StockData
PERRIGO Co plc logo

PERRIGO Co plc (PRGO) stock

PRGONYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 4, 2026Score 9/307% below fair value
$16.18−0.06 (-0.37%)

Close on Nov 16, 2026Market cap $2.25BP/E –Yield 7.17%

Perrigo price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Perrigo's price to sales ratio was 0.6× on Nov 11, 2026, against 0.4× a year earlier. Over the last 5 years it ranged from 0.3× to 1.3×, with a median of 0.9×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.6×+0.1
2025Dec 31, 20250.4×−0.4
2024Dec 31, 20240.8×−0.1
2023Dec 29, 20230.9×−0.1
2022Dec 30, 20221.0×−0.2
2021Dec 31, 20211.2×−0.2
2020Dec 31, 20201.4×−0.1
2019Dec 31, 20191.5×+0.4
2018Dec 31, 20181.1×−1.8
2017Dec 29, 20172.9×+0.0
2016Dec 30, 20162.9×−2.1
2015Dec 31, 20155.0×−0.6
2014Dec 31, 20145.6×+5.6
2013Dec 31, 20130.0×–

More Perrigo figures

See a number that looks wrong?